Search Results - "Cui, Chuanjue"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion by Shi, Qiang, Liu, Xiaoyan, Bai, Yuanyuan, Cui, Chuanjue, Li, Jun, Li, Yishi, Hu, Shengshou, Wei, Yingjie

    Published in PloS one (23-11-2011)
    “…Cardiac fibroblasts (CFs) are the primary cell type responsible for cardiac fibrosis during pathological myocardial remodeling. Several studies have…”
    Get full text
    Journal Article
  2. 2

    Lipocalin-2 Promotes Endoplasmic Reticulum Stress and Proliferation by Augmenting Intracellular Iron in Human Pulmonary Arterial Smooth Muscle Cells by Wang, Guoliang, Liu, Shenghua, Wang, Li, Meng, Liukun, Cui, Chuanjue, Zhang, Hao, Hu, Shengshou, Ma, Ning, Wei, Yingjie

    “…Endoplasmic reticulum (ER) stress, a feature of many conditions associated with pulmonary hypertension (PH), is increasingly recognized as a common response to…”
    Get full text
    Journal Article
  3. 3

    Up-regulated lipocalin-2 in pulmonary hypertension involving in pulmonary artery SMC resistance to apoptosis by Wang, Guoliang, Liu, Xiaoyan, Meng, Liukun, Liu, Shenghua, Wang, Li, Li, Jun, Cui, Chuanjue, Meng, Jian, Hu, Shengshou, Wei, Yingjie

    “…A key feature of pulmonary hypertension (PH) is the remodeling of small pulmonary arteries due to abnormal pulmonary artery smooth muscle cell (PASMC)…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-κB-dependent pathway by QIANHONG LI, YIRU GUO, WEI TAN, QINGHUI OU, WU, Wen-Jian, STURZA, Diana, DAWN, Buddhadeb, HUNT, Greg, CHUANJUE CUI, BOLLI, Roberto

    Published in Circulation (New York, N.Y.) (02-10-2007)
    “…Background— Gene therapy with inducible nitric oxide synthase (iNOS) markedly reduces myocardial infarct size; this effect is associated with cyclooxygenase-2…”
    Get full text
    Journal Article
  6. 6

    Elevation of IGF‐2 receptor and the possible underlying implications in end‐stage heart failure patients before and after heart transplantation by Wei, Yingjie, Li, Jun, Huang, Jie, Zhang, Xiaoling, Zhao, Hong, Cui, Chuanjue, Li, Yishi, Hu, Shengshou

    Published in Journal of cellular and molecular medicine (01-05-2012)
    “…Up‐regulation of insulin‐like growth factor 2 receptor (IGF‐2R) involved in angiotensin II–induced cell apoptosis in cardiomyoblasts, and correlated with…”
    Get full text
    Journal Article
  7. 7

    Carvedilol preserves endothelial junctions and reduces myocardial no-reflow after acute myocardial infarction and reperfusion by Zhao, Jinglin, Yang, Yuejin, you, Shijie, Cui, Chuanjue, Gao, Runlin

    Published in International journal of cardiology (14-02-2007)
    “…Abstract Introduction Myocardial no-reflow, has been associated with alterations in endothelial junctions, which is regulated in part by endothelial…”
    Get full text
    Journal Article
  8. 8

    Anticoagulant Hydrogel Tubes with Poly(ɛ‐Caprolactone) Sheaths for Small‐Diameter Vascular Grafts by Zhang, Chunliang, Xie, Qian, Cha, Ruitao, Ding, Li, Jia, Liujun, Mou, Lei, Cheng, Shiyu, Wang, Nuoxin, Li, Zulan, Sun, Yang, Cui, Chuanjue, Zhang, Yu, Zhang, Yan, Zhou, Fengshan, Jiang, Xingyu

    Published in Advanced healthcare materials (01-10-2021)
    “…Small‐diameter vascular grafts (inner diameter < 6 mm) are useful in treating cardiovascular diseases. The off‐the‐shelf small‐diameter vascular grafts for…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Inhibitory effect of NBL1 on PDGF-BB-induced human PASMC proliferation through blockade of PDGFβ-p38MAPK pathway by Cui, Chuanjue, Zhang, Hongliang, Guo, Lin-Na, Zhang, Xiaoling, Meng, Liukun, Pan, Xiangbin, Wei, Yingjie

    Published in Bioscience reports (01-08-2016)
    “…Pulmonary artery remodelling is a key feature in the pathological progress of pulmonary arterial hypertension (PAH). Moreover, excessive proliferation of…”
    Get full text
    Journal Article
  12. 12

    Dermatopontin promotes adhesion, spreading and migration of cardiac fibroblasts in vitro by Liu, Xiaoyan, Meng, Liukun, Shi, Qiang, Liu, Shenghua, Cui, Chuanjue, Hu, Shengshou, Wei, Yingjie

    Published in Matrix biology (01-01-2013)
    “…Dermatopontin (DPT), an extracellular matrix (ECM) protein, has been previously shown to be upregulated in the infarct zone of experimentally induced…”
    Get full text
    Journal Article
  13. 13

    CRP promotes MMP-10 expression via c-Raf/MEK/ERK and JAK1/ERK pathways in cardiomyocytes by Cui, Chuanjue, Shi, Qiang, Zhang, Xiaoling, Liu, Xiaoyan, Bai, Yuanyuan, Li, Jun, Liu, Shenghua, Hu, Shengshou, Wei, Yingjie

    Published in Cellular signalling (01-03-2012)
    “…C-reactive protein (CRP) was reported to be a predictor for left ventricular (LV) remodeling. Matrix metalloproteinase (MMP)-10 participates in the LV…”
    Get full text
    Journal Article
  14. 14

    Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease by DU, Ying, Yang, Sheng Hua, Li, Sha, Cui, Chuan Jue, Zhang, Yan, Zhu, Cheng Gang, Guo, Yuan Lin, Wu, Na Qiong, Gao, Ying, Sun, Jing, Dong, Qian, Liu, Geng, Li, Jian Jun

    Published in Biomedical and environmental sciences (01-08-2016)
    “…Very early-onset coronary artery disease (CAD) is a great challenge in cardiovascular medicine throughout the world, especially regarding its early diagnosis…”
    Get more information
    Journal Article
  15. 15

    Type‐specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end‐stage heart failure patients: relationship between MMP‐10 and LV remodelling by Wei, Yingjie, Cui, Chuanjue, Lainscak, Mitja, Zhang, Xiaoling, Li, Jun, Huang, Jie, Zhang, Hao, Zheng, Zhe, Hu, Shengshou

    Published in Journal of cellular and molecular medicine (01-04-2011)
    “…Although past studies observed the changes of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in end‐stage heart failure…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway by Li, Qianhong, Guo, Yiru, Tan, Wei, Ou, Qinghui, Wu, Wen-Jian, Sturza, Diana, Dawn, Buddhadeb, Hunt, Greg, Cui, Chuanjue, Bolli, Roberto

    Published in Circulation (New York, N.Y.) (02-10-2007)
    “…Gene therapy with inducible nitric oxide synthase (iNOS) markedly reduces myocardial infarct size; this effect is associated with cyclooxygenase-2 (COX-2)…”
    Get full text
    Journal Article